Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Penta Valent Tbk. (PEVE) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Penta Valent Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Penta Valent Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 319B, 44.8K 24h volume), while Penta Valent Tbk. trades at Rp320 (market cap 572.06B, 837.4K 24h volume). The key difference: Penta Valent Tbk. is the larger of the two by market cap, and Penta Valent Tbk. is more actively traded (837.4K versus 44.8K). Which is the better fit depends on your goals.

DGNSPEVE
Market Cap
319B572.06B
Volume
44.8K837.4K
Lot
4488.37K
Turnover
10.23M267.74M
Average Price
228.26319.72
Value
10.23M267.74M
Indicative Equilibrium Price
232324
Indicative Equilibrium Volume
2005K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
PEVE
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Penta Valent Tbk.

PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.

Read more on PEVE